PRODUCT

CJC-1295 NO DAC (5 mg Vial)

No short description available.

Quickstart Highlights

CJC-1295 NO DAC dosage protocols leverage this synthetic 29‑amino‑acid GHRH analog (also known as Modified GRF 1–29 or Mod GRF) to stimulate natural, pulsatile growth hormone secretion from the pituitary gland[1][2]. Unlike exogenous GH administration, CJC-1295 NO DAC preserves the body’s physiologic feedback loop, supporting enhanced GH and IGF‑1 levels while maintaining natural hormonal rhythms[3][4]. Research suggests benefits may include improved body composition, enhanced recovery, better sleep quality, and support for lean muscle mass and metabolic function[5][6]. This educational protocol presents a practical once‑daily subcutaneous approach using a dilution optimized for clear insulin‑syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
Typical daily range: 100–300 mcg once daily (gradual titration).
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F); after reconstitution, refrigerate and use within 1–2 weeks; for longer storage, freeze at ≤−20 °C (≤−4 °F).

Reconstitution

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Protocol Overview

Goal:Stimulate pulsatile GH release and elevate IGF‑1 levels to support body composition, recovery, and overall metabolic health[2][5].
Schedule:Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range:100–300 mcg daily with gradual titration.
Reconstitution:3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
Storage:Lyophilized refrigerated or frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Dosage Protocols

Start:100–150 mcg daily; increase by ~50 mcg every 1–2 weeks as tolerated.
Target:200–300 mcg daily by Weeks 5–12.
Frequency:Once per day (subcutaneous), preferably at bedtime.
Cycle Length:8–12 weeks; optional extension to 16 weeks.
Timing:Administer at bedtime to align with natural nocturnal GH pulses; rotate injection sites.

Storage Instructions

Lyophilized:Store at 2–8 °C (35.6–46.4 °F); for extended storage, freeze at ≤−20 °C (≤−4 °F); minimize moisture exposure.
Reconstituted:Refrigerate at 2–8 °C (35.6–46.4 °F); use within 1–2 weeks; avoid freeze–thaw cycles.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
Administer on an empty stomach (fasted for ≥2 hours) to optimize GH response.

How It Works

CJC-1295 NO DAC (Modified GRF 1–29) is a truncated GHRH analog with four amino acid substitutions (D‑Ala2, Gln8, Ala15, Leu27) that enhance stability against enzymatic degradation[1]. It binds to GHRH receptors on pituitary somatotrophs, stimulating the synthesis and pulsatile release of endogenous growth hormone[2][3]. Unlike exogenous GH administration, GHRH analogs preserve the physiologic feedback loop, resulting in more natural GH pulsatility without the risks associated with supraphysiological GH levels[7]. The short half‑life (~30 minutes) produces discrete GH pulses that mimic the body’s natural secretion pattern[1][4].

Lifestyle Factors

Pair with a balanced, protein‑forward diet tailored to energy needs.
Combine resistance training and aerobic activity to reinforce metabolic adaptations and GH response.
Prioritize sleep and stress management to support natural GH pulsatility and recovery.
Administer peptide in a fasted state to maximize GH release.

Injection Technique

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[12][13].
Do not aspirate for subcutaneous injections; inject slowly and steadily[12].
Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[14].

Benefits and Side Effects

Benefits

Stimulates pulsatile GH release and elevates IGF‑1 levels with chronic administration[2][5][6].
May support improvements in body composition, including increased lean mass and reduced fat mass[8][9].
May enhance recovery, sleep quality, and overall energy levels[10].

CJC-1295 NO DAC (5 mg Vial)

Resources

Categories

Company